Corbevax, India’s first Heterologous Covid-19 booster vaccine.

• The Hyderabad-based pharmaceutical company Biological E’s recently approved heterologous Covid-19 vaccine, Corbevax is expected to be available as a booster dose on the COWIN App in both public and private vaccination centres .
• The company said. Corbevax was approved as India’s First Heterologous COVID-19 Booster Shot for 18 Years and above after the six months of administration of the primary vaccination doses of Covaxin or Covishield.

Who can take Corbevax booster shot?

• People who have taken Covaxin or Covishield can be administrated a Corbevax booster shot in “emergency use authorisation”. The Union Health Ministry approved Corbevax for emergency use on the basis of a recently made recommendation by the COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI).
• This approval came after the Drug Controller General of India (DCGI) approved the vaccine for emergency use as a heterologous COVID-19 booster dose for individuals aged 18 years on June 4, 2022.
• The Corbevax had received emergency use authorization as a primary two-dose vaccination regimen in Adults, Adolescents and Children aged 5 years and above, in a series of approvals from December`21 to April`22.

What is the price of Corbevax vaccine? 

• The price of Corbevax for private COVID-19 vaccination centres is Rs 250, inclusive of the Goods and Sales tax. For the end-user, the price of the vaccine is Rs 400, including taxes and administrative charges. Corbevax is expected to be available as a booster dose on the CoWIN App in public and private vaccination centres.